Hypertension

S Oparil, MC Acelajado, GL Bakris… - Nature reviews …, 2018 - pmc.ncbi.nlm.nih.gov
Systemic arterial hypertension is the most important modifiable risk factor for all-cause
morbidity and mortality worldwide and is associated with increased risk of cardiovascular …

The autonomic nervous system and hypertension

G Mancia, G Grassi - Circulation research, 2014 - Am Heart Assoc
Physiological studies have long documented the key role played by the autonomic nervous
system in modulating cardiovascular functions and in controlling blood pressure values …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy

PS Chen, LS Chen, MC Fishbein, SF Lin… - Circulation …, 2014 - Am Heart Assoc
Autonomic nervous system activation can induce significant and heterogeneous changes of
atrial electrophysiology and induce atrial tachyarrhythmias, including atrial tachycardia and …

Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association

RD Brook, LJ Appel, M Rubenfire, G Ogedegbe… - …, 2013 - Am Heart Assoc
Many antihypertensive medications and lifestyle changes are proven to reduce blood
pressure. Over the past few decades, numerous additional modalities have been evaluated …

The human sympathetic nervous system: its relevance in hypertension and heart failure

G Parati, M Esler - European heart journal, 2012 - academic.oup.com
Evidence assembled in this review indicates that sympathetic nervous system dysfunction is
crucial in the development of heart failure and essential hypertension. This takes the form of …

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on …

MH Olsen, SY Angell, S Asma, P Boutouyrie, D Burger… - The Lancet, 2016 - thelancet.com
Executive summary Elevated blood pressure is the strongest modifiable risk factor for
cardiovascular disease worldwide. Despite extensive knowledge about ways to prevent as …

New approaches in the treatment of hypertension

S Oparil, RE Schmieder - Circulation research, 2015 - Am Heart Assoc
Hypertension is the most common modifiable risk factor for cardiovascular disease and
death, and lowering blood pressure with antihypertensive drugs reduces target organ …

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal …

JD Bisognano, G Bakris, MK Nadim, L Sanchez… - Journal of the American …, 2011 - jacc.org
Objectives: We sought to determine the effect of baroreflex activation therapy (BAT) on
systolic blood pressure (SBP) in patients with resistant hypertension. Background: The …

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

UC Hoppe, MC Brandt, R Wachter, J Beige… - Journal of the American …, 2012 - Elsevier
BACKGROUND: Previous trials have demonstrated clinically significant and durable
reductions in arterial pressure from baroreflex activation therapy (BAT), resulting from …